Application of mass spectrometric techniques to delineate the modes-of-action of anticancer metallodrugs

Christian G. Hartinger, Michael Groessl, Samuel M. Meier, Angela Casini, Paul J. Dyson

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung

135 Zitate (Scopus)

Abstract

Mass spectrometry (MS) has emerged as an important tool for studying anticancer metallodrugs in complex biological samples and for characterising their interactions with biomolecules and potential targets on a molecular level. The exact modes-of-action of these coordination compounds and especially of next generation drug candidates have not been fully elucidated. Due to the fact that DNA is considered a crucial target for platinum chemotherapeutics, metallodrug–DNA binding studies dominated the field for a long time. However, more recently, alternative targets were considered, including enzymes and proteins that may play a role in the overall pharmacological and toxicological profile of metallodrugs. This review focuses on MS-based techniques for studying anticancer metallodrugs in vivo, in vitro and in situ to delineate their modes-of-action.

OriginalspracheEnglisch
Seiten (von - bis)6186-6199
Seitenumfang14
FachzeitschriftChemical Society Reviews
Jahrgang42
Ausgabenummer14
DOIs
PublikationsstatusVeröffentlicht - 24 Juni 2013
Extern publiziertJa

Fingerprint

Untersuchen Sie die Forschungsthemen von „Application of mass spectrometric techniques to delineate the modes-of-action of anticancer metallodrugs“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren